Cannabis Science Negotiates Several Commercialization Deals To Make Its Anti-Cancer Cannabis Formulations Available To The Public

Cannabis Science, Inc. (CBIS) announces negotiations with several commercialization groups to bring its anti-cancer cannabis formulations to the public as soon as possible. This collection of public data will be a major contribution to the body of evidence that will guide our Investigative New Drug Applications to the FDA for critical ailments such as cancer.